Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-08-20

Clinical Trial Update: Gabapentin for the Treatment of Pruritus Caused by Burn Injuries in Children [Phase 1]

View source ↗

Summary

This clinical trial update indicates that a Phase 1 study of gabapentin to treat pruritus from burn injuries in children has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Pruritus | Phase 1 | Status: WITHDRAWN